MASTL and breast cancer: We also determined whether MKI-1 increased aberrant nuclei in MCF7 cells, as we had previously observed that MASTL depletion increased aberrant nuclei such as nuclei with irregular shapes or fragmented nuclei in breast cancer cells (14).